Cargando…

Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.

OBJECTIVE: Group B streptococcal (GBS) vulvovaginitis is a poorly-delineated clinical entity. The purpose of this study is to report semiquantitative data from four cases of GBS vulvovaginitis and to comment on their significance in terms of the in vitro inhibitory capabilities of GBS. METHODOLOGY:...

Descripción completa

Detalles Bibliográficos
Autor principal: Monif, G R
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784754/
https://www.ncbi.nlm.nih.gov/pubmed/10524667
http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:5<227::AID-IDOG4>3.0.CO;2-D
_version_ 1782132096919142400
author Monif, G R
author_facet Monif, G R
author_sort Monif, G R
collection PubMed
description OBJECTIVE: Group B streptococcal (GBS) vulvovaginitis is a poorly-delineated clinical entity. The purpose of this study is to report semiquantitative data from four cases of GBS vulvovaginitis and to comment on their significance in terms of the in vitro inhibitory capabilities of GBS. METHODOLOGY: Four patients whose clinical presentations were consistent with GBS vulvovaginitis, from whom GBS was isolated and for whom semi-quantitative as well as qualitative microbiologic data existed, were identified. RESULTS: To produce vulvovaginitis, GBS must be at a high multiplicity (10(8) CFU/g of vaginal fluid). Single coisolates were identified in three of the four cases (two cases of Escherichia coli and one case of Staphylococcus aureus). Group B streptococcus does not inhibit either of these bacteria in vitro. CONCLUSION: When the growth requirements for the demonstration of in vitro inhibition for GBS or lack thereof are met in vivo, the in vivo observations are consistent with those projected from the in vitro data.
format Text
id pubmed-1784754
institution National Center for Biotechnology Information
language English
publishDate 1999
record_format MEDLINE/PubMed
spelling pubmed-17847542007-02-05 Semiquantitative bacterial observations with group B streptococcal vulvovaginitis. Monif, G R Infect Dis Obstet Gynecol Research Article OBJECTIVE: Group B streptococcal (GBS) vulvovaginitis is a poorly-delineated clinical entity. The purpose of this study is to report semiquantitative data from four cases of GBS vulvovaginitis and to comment on their significance in terms of the in vitro inhibitory capabilities of GBS. METHODOLOGY: Four patients whose clinical presentations were consistent with GBS vulvovaginitis, from whom GBS was isolated and for whom semi-quantitative as well as qualitative microbiologic data existed, were identified. RESULTS: To produce vulvovaginitis, GBS must be at a high multiplicity (10(8) CFU/g of vaginal fluid). Single coisolates were identified in three of the four cases (two cases of Escherichia coli and one case of Staphylococcus aureus). Group B streptococcus does not inhibit either of these bacteria in vitro. CONCLUSION: When the growth requirements for the demonstration of in vitro inhibition for GBS or lack thereof are met in vivo, the in vivo observations are consistent with those projected from the in vitro data. 1999 /pmc/articles/PMC1784754/ /pubmed/10524667 http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:5<227::AID-IDOG4>3.0.CO;2-D Text en
spellingShingle Research Article
Monif, G R
Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title_full Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title_fullStr Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title_full_unstemmed Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title_short Semiquantitative bacterial observations with group B streptococcal vulvovaginitis.
title_sort semiquantitative bacterial observations with group b streptococcal vulvovaginitis.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784754/
https://www.ncbi.nlm.nih.gov/pubmed/10524667
http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:5<227::AID-IDOG4>3.0.CO;2-D
work_keys_str_mv AT monifgr semiquantitativebacterialobservationswithgroupbstreptococcalvulvovaginitis